Affimed

-$0.18 (-2.64%) Today
+$0.07 (+1.05%) As of 11:05 PM UTC after-hours

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell Affimed and other ETFs, options, and stocks.

About AFMD

Affimed NV engages in the discovery and development of cancer immunotherapies. It offers ROCK novel proprietary antibody platform, which delivers types of next-generation tetravalent antibody formats, including bispecific and trispecific innate cell engagers.

CEO
Adolf Hoess
Employees
163
Headquarters
Heidelberg, Baden Wuerttemberg
Founded
2000

AFMD Key Statistics

Market Cap
950.86M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
905.48K
High Today
$6.97
Low Today
$6.63
Open Price
$6.80
Volume
820.97K
52 Week High
$11.74
52 Week Low
$3.07

AFMD Earnings

-$0.21
-$0.14
-$0.06
$0.01
Q4 FY19
Q1 FY20
Q2 FY20
Q3 FY20
Q4 FY20
Q1 FY21
Q2 FY21
Estimated
— per share
Actual
Expected Aug 19, Pre-Market
Replay Earnings Call
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure